Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.

Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China. Chin Med J (Engl) (2015) 0.75

IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J (1993) 5.46

Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet (1995) 5.07

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med (1997) 3.49

HIV counseling and testing of pregnant women in sub-Saharan Africa: experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr (2001) 2.81

Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet (1986) 2.38

Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci U S A (2001) 2.33

Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost (2006) 2.32

Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis (1996) 2.15

Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am J Psychiatry (2000) 2.12

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology (2004) 2.10

Evidence-based or traditional treatment of cancer-related lymphedema. Lymphology (2015) 1.98

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia (2011) 1.79

Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem J (1987) 1.76

Transvaginal ultrasonography and endometrial histology in peri- and postmenopausal women on hormone replacement therapy. Br J Obstet Gynaecol (1999) 1.72

Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut (2005) 1.70

Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol (2000) 1.66

Immune deficiency in family members of patients with Hodgkin's disease. Cancer (1990) 1.61

The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model. Bone Marrow Transplant (2008) 1.56

Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells. Oncogene (2012) 1.55

Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study. Eur J Haematol (2002) 1.55

Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration. Chest (1995) 1.55

Prevalence of back pain in pregnancy. Spine (Phila Pa 1976) (1991) 1.53

Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res (2000) 1.52

10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem (1994) 1.49

The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol (1995) 1.49

Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br J Haematol (1995) 1.49

Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance. Eur J Haematol (1989) 1.48

Congenital dyserythropoietic anemia type III. Haematologica (2000) 1.47

The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia (2006) 1.47

The outcome of diabetic pregnancies in relation to the mother's blood sugar level. Am J Obstet Gynecol (1972) 1.46

Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia. Lancet (1985) 1.46

Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden. Epidemiol Infect (1994) 1.45

Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer. Transplantation (2000) 1.45

Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease. Br J Haematol (1996) 1.45

Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia. Br J Haematol (1994) 1.41

Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia? Leuk Lymphoma (2009) 1.41

Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene (2000) 1.41

[Ambulance services are not to be jeopardized by labor unions]. Lakartidningen (1997) 1.40

[Complications of anticoagulants. Frequency of fatal bleedings justifies more rigid indications]. Lakartidningen (1995) 1.39

Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci (1998) 1.37

Transplantation of peripheral blood progenitor cells from unrelated donors. Transplantation (1998) 1.37

Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.34

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients. Leukemia (2009) 1.34

Geriatric-based versus general wards for older acute medical patients: a randomized comparison of outcomes and use of resources. J Am Geriatr Soc (2000) 1.29

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant (1998) 1.27

Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke (2001) 1.26

Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood (1998) 1.19

Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant (2012) 1.17

Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers. Vaccine (1995) 1.17

Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res (2004) 1.17

Lymphocyte abnormalities in untreated patients with Hodgkin's disease. Cancer (1976) 1.17

Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation. Blood (1999) 1.13

Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci (2001) 1.12

Evaluation of methods for enumerating microorganisms in filter samples from highly contaminated occupational environments. Am Ind Hyg Assoc J (1990) 1.10

Heparin-affinity patterns and composition of extracellular superoxide dismutase in human plasma and tissues. Biochem J (1993) 1.10

Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: identification of stages of maturation arrest and the relation to clinical findings. Blood (1983) 1.10

Interferon therapy in myelomatosis. Lancet (1979) 1.10

Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping. Leukemia (2004) 1.08

Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant (1998) 1.07

Impairment of renal concentrating capacity by lithium. Lancet (1978) 1.06

Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT. Bone Marrow Transplant (2007) 1.06

Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. Hum Mol Genet (1995) 1.05

Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers. Vaccine (1993) 1.05

Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival. Bone Marrow Transplant (2006) 1.04

Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin Chem (2001) 1.04

Evaluation of six commercially available kits using purified heterophile antigen for the rapid diagnosis of infectious mononucleosis compared with Epstein-Barr virus-specific serology. Clin Diagn Virol (1996) 1.03

Natural killer cell activity in monoclonal gammopathies: relation to disease activity. Eur J Haematol (1990) 1.03

Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br J Cancer (1999) 1.03

Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes. Br J Haematol (1998) 1.02

Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis (1999) 1.01

Blood T-lymphocyte functions in healthy adults in relation to age. Scand J Haematol (1982) 1.01

Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell transplantation. Eur J Cancer Care (Engl) (2001) 1.01

Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival. Leukemia (2006) 1.01

Central nervous system and ophthalmic involvement in nephropathia epidemica (European type of haemorrhagic fever with renal syndrome). J Infect (1998) 1.01

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction. Transpl Infect Dis (2009) 1.00

Optimization of the detection of microbes in blood from immunocompromised patients with haematological malignancies. Clin Microbiol Infect (2009) 1.00

Amplification of the c-myc oncogene in human plasma-cell leukemia. Int J Cancer (1985) 0.99

The humoral antibody response to Shigella dysenteriae type 1 infection, as determined by ELISA. Bull World Health Organ (1984) 0.99

Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica. FEMS Immunol Med Microbiol (1998) 0.99

Persisting lymphocyte deficiences during remission in Hodgkin's disease. Clin Exp Immunol (1977) 0.99

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. Ann Oncol (2012) 0.98

In vitro photochemical cataract in mice lacking copper-zinc superoxide dismutase. Free Radic Biol Med (2001) 0.98

Pharmacokinetic and metabolic studies of high-dose busulphan in adults. Eur J Clin Pharmacol (1989) 0.98

Interleukin-10 gene promoter polymorphisms in multiple myeloma. Int J Cancer (2001) 0.98

Individual quality of life in long-term survivors of Hodgkin's lymphoma--a comparative study. Qual Life Res (2003) 0.98

Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea. Eur J Haematol (1988) 0.97

Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis (1999) 0.97

Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument. Psychooncology (2008) 0.96

Urine microscopy as screening method for bacteriuria. Acta Med Scand (1982) 0.96

The clinical usefulness of a Puumalavirus recombinant nucleocapsid protein based enzyme-linked immunosorbent assay in the diagnosis of nephropathia epidemica as compared with an immunofluorescence assay. Clin Diagn Virol (1996) 0.96

Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications. Adv Cancer Res (1984) 0.95

Intravascular haemolysis and increased prevalence of myeloma and monoclonal gammopathy in congenital dyserythropoietic anaemia, type III. Eur J Haematol (1994) 0.95

Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity? Ann Oncol (2002) 0.95

Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124. J Infect (1994) 0.95

A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Hematol (2000) 0.94

Application and usefulness of enzyme immunoassay for diagnosis of Salmonella typhimurium infection. Scand J Infect Dis (1980) 0.93

Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients. Br J Haematol (1996) 0.93